Profile: Haemoscope Corp., a part of Haemonetics Corporation specializes in Thrombelastograph (TEG®) system. The TEG® is comprised of the TEG® analyzer and the TEG® analytical software, which together provide a complete picture of the formation & dissolution of the clot, showing the balance or imbalance of the two systems. It can pinpoint the causes of a coagulopathy and can identify the targeted treatment needed for improved patient outcomes - to envision the balance or identify the imbalance. It provides vibration damping in its software. It uses simple principles in the design and operation of its analyzer hardware. We provide software-assisted diagnostics, overlaying of multiple tracings for easy visual comparison, and user/clinician connectivity across the hospital & around the world.

The company was founded in 1976, has revenues of USD 5-10 Million, has ~30 employees.